News and updates

Viewing:

All Years 2024 2023 2022 & Older

June 6, 2022

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

EMERYVILLE, Calif. & ALBANY, N.Y. –(BUSINESS WIRE)– Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia a leading contract research, development and manufacturing organization (CDMO), today announced Curia’s adoptio...

April 28, 2022

Curia completes “Center of Speed” expansion with new GMP suites

Curia, a leading global contract research, development, and manufacturing organization expands its small scale GMP-compliant capacity with the investment of new suites to support Orphan/Accelerated products with improved timeline, in-house analytical...

March 24, 2022

Curia Recognized on Forbes America’s Best Employers 2022 List

ALBANY, N.Y–(BUSINESS WIRE)–Curia a leading contract research, development, and manufacturing organization, today announced that it has been recognized on Forbes list of America’s Best Employers 2022, presented by Forbes and Statista Inc. The a...

March 9, 2022

Curia Enters Cooperative Agreement with U.S. Government to Expand Sterile Fill-Finish Capability

Additional High-Speed Line Adds BSL2 Capacity in the U.S.

February 14, 2022

Integrity Bio and LakePharma Become Curia

Companies Unite Under One Brand to Provide Seamless, Comprehensive Biologics Discovery, Development and Manufacturing Solutions

December 22, 2021

Curia Unveils Comprehensive mRNA Solution

Curia’s mRNA Services Combine Comprehensive Experience and Flexible Capabilities from Discovery Through Fill-Finish Manufacturing

September 2, 2021

Curia Completes Acquisition of LakePharma

ALBANY, N.Y.–(BUSINESS WIRE)–Curia a leading contract research, development and manufacturing organization, today announced it has completed the transaction to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research...

August 19, 2021

Curia to Expand U.S. Commercial Manufacturing Capability

Albany, NY – August 19, 2021 – Curia a leading contract research, development and manufacturing organization, today announced plans to expand its commercial manufacturing capacity at its Rensselaer, New York facility. The increased capability to...

August 4, 2021

Curia Completes Acquisition of Integrity Bio: Transaction adds biologic capabilities, expands capacity

Albany, NY – August 4, 2021 – Curia a leading contract research, development and manufacturing organization, today announced it has completed the transaction to acquire Integrity Bio, Inc., a privately held formulation and fill-finish organizatio...

July 14, 2021

Curia to Acquire US-Based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

ALBANY, N.Y.–(BUSINESS WIRE)–Curia a leading contract research, development and manufacturing organization, today announced it has entered into a definitive agreement to acquire LakePharma Inc., a privately held biologics drug discovery, clinical...

July 13, 2021

Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities

ALBANY, N.Y.–(BUSINESS WIRE)–Curia a leading contract research, development and manufacturing organization, today announced it has entered into a definitive agreement to acquire Integrity Bio, Inc., a privately held formulation and fill-finish or...

July 12, 2021

AMRI becomes Curia

Albany Molecular Research, Inc. (AMRI), a leading global contract research, development and manufacturing organization serving the pharmaceutical and biopharmaceutical industries, today announced that it is changing its name to Curia, effective July...

1 2 3 4

Ready to move from idea to impact?

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

Get started